Anticoagulants were not used according to guidelines, despite evidence they prevent strokes DURHAM, N.C. March 15, 2017 – More than 80 percent of stroke patients with a history of atrial fibrillation either received not enough or no anticoagulation therapy prior to having a stroke, despite the drugs’ proven record of reducing stroke risk, according to […]
The findings advance progress toward HIV vaccine design DURHAM, N.C. March 15, 2017 – A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination. “A goal for an HIV-1 vaccine is to induce […]
A shorter regimen is scientifically sound, but most women still get the longer therapy DURHAM, N.C. March 14, 2017 – More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke […]
Only Anti-PD-1 Therapy Approved for the Treatment of Patients with Difficult-to-Treat cHL Regardless of Prior Stem Cell Transplantation or Use of Brentuximab Vedotin KENILWORTH, N.J. March 14, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the […]
KENILWORTH, N.J. March 14, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has extended the action date for the supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, for previously treated patients with advanced microsatellite instability-high (MSI-H) […]
Findings raise caution for women of childbearing age DURHAM, N.C. March 13, 2017 – Exposure to second-hand tobacco smoke — even before conception — appears to have a lingering impact that can later impair the brain development of a fetus, researchers at Duke Health report. Using rats in experiments carefully designed to mimic the second-hand […]
Small study shows that the interactive game prompted people to walk more steps a day DURHAM, N.C. March 9, 2017 – The Pokémon Go craze that spurred millions of people to collect virtual monsters via a smart phone app might have also had a health benefit by encouraging people to get up and walk. A […]
Oral Dydrogesterone has the potential to become new treatment of choice for an estimated 1.5 million women worldwide who undergo IVF treatment each year (1, 2) ABBOTT PARK, Ill., March 8, 2017 /PRNewswire/ — New study results published in Human Reproduction could pave the way for an additional treatment option for the estimated 1.5 million […]
Investigational SGLT2 Inhibitor Submitted as Monotherapy and in Fixed-Dose Combinations with JANUVIA ® (sitagliptin) or Metformin KENILWORTH, N.J. & NEW YORK – March 6, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:FE), today announced that the U.S. Food and Drug Administration (FDA) has accepted for review […]
Lilly to present head-to-head 24-week data comparing the efficacy and safety of Taltz and Stelara for the treatment of moderate-to-severe plaque psoriasis INDIANAPOLIS, March 4, 2017 /CNW/ — Eli Lilly and Company (NYSE: LLY) announced today that patients with moderate-to-severe plaque psoriasis treated with Taltz® (ixekizumab) demonstrated superior efficacy at 24 weeks compared to patients […]
